Published in

Dove Press, Drug Design, Development and Therapy, (Volume 14), p. 5441-5450, 2020

DOI: 10.2147/dddt.s266177

Links

Tools

Export citation

Search in Google Scholar

Budesonide/Formoterol Anti-Inflammatory Reliever and Maintenance or Fluticasone Propionate/Salmeterol Plus As-Needed, Short-Acting β<sub>2</sub> Agonist: Real-World Effectiveness in pAtients without Optimally Controlled asThma (REACT) Study

Journal article published in 2020 by Shih-Lung Cheng, Ming-Lin Ho, Yun-Fa Lai, Hao-Chien Wang, Jeng-Yuan Hsu ORCID, Shih-Feng Liu, Ming-Shyang Huang ORCID, Cheng-Hung Lee, Ching-Hsiung Lin, Liang-Wen Hang ORCID, Yu-Chih Liu, Kuang-Yao Yang ORCID, Jia-Horng Wang
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Red circle
Preprint: archiving forbidden
Green circle
Postprint: archiving allowed
Upload
Green circle
Published version: archiving allowed
Upload
Policy details
Data provided by SHERPA/RoMEO